These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 25202981

  • 1. miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways.
    Wang H, Sun T, Hu J, Zhang R, Rao Y, Wang S, Chen R, McLendon RE, Friedman AH, Keir ST, Bigner DD, Li QJ, Wang H, Wang XF.
    J Clin Invest; 2014 Oct; 124(10):4489-502. PubMed ID: 25202981
    [Abstract] [Full Text] [Related]

  • 2. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
    Yi L, Zhou X, Li T, Liu P, Hai L, Tong L, Ma H, Tao Z, Xie Y, Zhang C, Yu S, Yang X.
    J Exp Clin Cancer Res; 2019 Aug 05; 38(1):339. PubMed ID: 31382985
    [Abstract] [Full Text] [Related]

  • 3. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
    Li Y, Wang W, Wang F, Wu Q, Li W, Zhong X, Tian K, Zeng T, Gao L, Liu Y, Li S, Jiang X, Du G, Zhou Y.
    J Mol Cell Biol; 2017 Aug 01; 9(4):302-314. PubMed ID: 28486630
    [Abstract] [Full Text] [Related]

  • 4. A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.
    Saito N, Fu J, Zheng S, Yao J, Wang S, Liu DD, Yuan Y, Sulman EP, Lang FF, Colman H, Verhaak RG, Yung WK, Koul D.
    Stem Cells; 2014 Jan 01; 32(1):301-12. PubMed ID: 24038660
    [Abstract] [Full Text] [Related]

  • 5. Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells.
    López-Valero I, Dávila D, González-Martínez J, Salvador-Tormo N, Lorente M, Saiz-Ladera C, Torres S, Gabicagogeascoa E, Hernández-Tiedra S, García-Taboada E, Mendiburu-Eliçabe M, Rodríguez-Fornés F, Sánchez-Domínguez R, Segovia JC, Sánchez-Gómez P, Matheu A, Sepúlveda JM, Velasco G.
    Theranostics; 2020 Jan 01; 10(11):5120-5136. PubMed ID: 32308772
    [Abstract] [Full Text] [Related]

  • 6. Tumorigenic potential of miR-18A* in glioma initiating cells requires NOTCH-1 signaling.
    Turchi L, Debruyne DN, Almairac F, Virolle V, Fareh M, Neirijnck Y, Burel-Vandenbos F, Paquis P, Junier MP, Van Obberghen-Schilling E, Chneiweiss H, Virolle T.
    Stem Cells; 2013 Jul 01; 31(7):1252-65. PubMed ID: 23533157
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
    Bier A, Giladi N, Kronfeld N, Lee HK, Cazacu S, Finniss S, Xiang C, Poisson L, deCarvalho AC, Slavin S, Jacoby E, Yalon M, Toren A, Mikkelsen T, Brodie C.
    Oncotarget; 2013 May 01; 4(5):665-76. PubMed ID: 23714687
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
    Xia Z, Wei P, Zhang H, Ding Z, Yang L, Huang Z, Zhang N.
    Mol Cancer Res; 2013 Sep 01; 11(9):1101-11. PubMed ID: 23761169
    [Abstract] [Full Text] [Related]

  • 11. The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network.
    Fareh M, Turchi L, Virolle V, Debruyne D, Almairac F, de-la-Forest Divonne S, Paquis P, Preynat-Seauve O, Krause KH, Chneiweiss H, Virolle T.
    Cell Death Differ; 2012 Feb 01; 19(2):232-44. PubMed ID: 21720384
    [Abstract] [Full Text] [Related]

  • 12. CDK5 Inhibition Resolves PKA/cAMP-Independent Activation of CREB1 Signaling in Glioma Stem Cells.
    Mukherjee S, Tucker-Burden C, Kaissi E, Newsam A, Duggireddy H, Chau M, Zhang C, Diwedi B, Rupji M, Seby S, Kowalski J, Kong J, Read R, Brat DJ.
    Cell Rep; 2018 May 08; 23(6):1651-1664. PubMed ID: 29742423
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
    Lulli V, Buccarelli M, Ilari R, Castellani G, De Dominicis C, Di Giamberardino A, D Alessandris QG, Giannetti S, Martini M, Stumpo V, Boe A, De Luca G, Biffoni M, Marziali G, Pallini R, Ricci-Vitiani L.
    Int J Mol Sci; 2020 May 20; 21(10):. PubMed ID: 32443824
    [Abstract] [Full Text] [Related]

  • 16. Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis.
    Huynh TT, Lin CM, Lee WH, Wu AT, Lin YK, Lin YF, Yeh CT, Wang LS.
    J Nutr Biochem; 2015 May 20; 26(5):466-75. PubMed ID: 25736407
    [Abstract] [Full Text] [Related]

  • 17. Suppression of SIRT6 by miR-33a facilitates tumor growth of glioma through apoptosis and oxidative stress resistance.
    Chang M, Qiao L, Li B, Wang J, Zhang G, Shi W, Liu Z, Gu N, Di Z, Wang X, Tian Y.
    Oncol Rep; 2017 Aug 20; 38(2):1251-1258. PubMed ID: 28677777
    [Abstract] [Full Text] [Related]

  • 18. MOB2 suppresses GBM cell migration and invasion via regulation of FAK/Akt and cAMP/PKA signaling.
    Jiang K, Yao G, Hu L, Yan Y, Liu J, Shi J, Chang Y, Zhang Y, Liang D, Shen D, Zhang G, Meng S, Piao H.
    Cell Death Dis; 2020 Apr 14; 11(4):230. PubMed ID: 32286266
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phage display discovery of novel molecular targets in glioblastoma-initiating cells.
    Liu JK, Lubelski D, Schonberg DL, Wu Q, Hale JS, Flavahan WA, Mulkearns-Hubert EE, Man J, Hjelmeland AB, Yu J, Lathia JD, Rich JN.
    Cell Death Differ; 2014 Aug 14; 21(8):1325-39. PubMed ID: 24832468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.